Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has informed the stock exchanges that its trading window for dealing in company securities will be closed starting January 1, 2026. The window will reopen 48 hours after the company declares its unaudited financial results for the third quarter and nine-month period ending December 31, 2025. The date of the board meeting to approve these Q3 results will be announced separately in due course. This is a routine compliance requirement under SEBI's insider trading regulations to prevent insiders from trading while in possession of unpublished financial information.
This is a standard regulatory filing and does not have a direct impact on the stock price. However, it signals that Q3 FY26 results are likely to be announced in mid-to-late January 2026, and investors should watch for the upcoming earnings release.